Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AXON$422.00+7.40(+1.78%)Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more...[1:00:00 PM ET]PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

BUDA · AMEX

Buda Juice Inc.

$6.60 -0.10 (-1.49%)

Company overview

Buda Juice, LLC produces and sells cold-pressed, organic juices. The company provides USDA certified organic, cold-pressed juices made from fruits and vegetables, available in glass bottles. Its offerings include juice cleanses ranging from one to five days, ginger and turmeric shots sold in bulk packs, citrus-based juices under the Buda Zen brand, organic soups, and plant-based milks. All products are kept refrigerated from production to sale to maintain freshness. The company serves wholesale clients. It was founded in 2013 and is based in Dallas, Texas.

Sector
Consumer Defensive
Industry
Beverages - Non-Alcoholic
Exchange
AMEX
Market cap
$82.9M
Employees
40
Headquarters
Dallas, TX
Website
budajuice.com
CEO
Horatio Lonsdale-Hands
Listed
August 17, 2018
P/E
0.00
Dividend yield
0.00%

Company financials

Total assets
$22.9M
Total debt
$749,000

Price chart

6.027.579.1210.6812.23
BUDA 1D AMEX O7.10H7.10L6.53C6.60-0.10 (-1.49%)Vol4.84K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
BUDA Stock news BUDA Details Ultra Fresh Expansion, New Plants and Wholesale Growth Strategy MarketBeat
BUDA Stock news Buda Juice to Participate in the LD Micro 20th Annual Main Event on October 20, 2026 Business Wire
BUDA Stock news BUDA Q2 Earnings Call Highlights MarketBeat
BUDA Press release Buda Juice Reports Second Quarter 2026 Financial Results Business Wire
BUDA Press release Buda Juice Announces Second Quarter Fiscal 2026 Financial Results Conference Call and Webcast Business Wire
BUDA Press release Buda Juice to Present at the Planet MicroCap Las Vegas 2026 Conference Powered by MicroCapClub Business Wire
BUDA Press release Buda Juice Reports First Quarter Fiscal 2026 Financial Results Business Wire
BUDA Press release Buda Juice Expands Distribution Across Nine States Business Wire
BUDA Press release Buda Juice Announces First Quarter Fiscal 2026 Financial Results Conference Call and Webcast Business Wire
BUDA Press release Buda Juice CEO Horatio Lonsdale-Hands Named Finalist For The EY US Entrepreneur Of The Year 2026 Southwest Award Business Wire
BUDA Stock news Buda Juice: The Optionality Isn't Mine Seeking Alpha
BUDA Press release Buda Juice Reports Full Year Fiscal 2025 Financial Results Business Wire
BUDA Press release Buda Juice Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results Conference Call and Webcast GlobeNewsWire
BUDA Stock news BUDA’s (NYSEAMERICAN:BUDA) Quiet Period Set To Expire on February 17th Defense World
BUDA Stock news Buda Juice: A Cold Chain Story With Hot IPO Expectations Seeking Alpha
BUDA Press release Buda Juice Commences Trading on NYSE American Exchange GlobeNewsWire
BUDA Press release Buda Juice Announces Pricing of $20 Million Initial Public Offering GlobeNewsWire
See more
FAQ

Questions about Buda Juice Inc.

What does Buda Juice Inc. do?
Buda Juice, LLC produces and sells cold-pressed, organic juices. The company provides USDA certified organic, cold-pressed juices made from fruits and vegetables, available in glass bottles. Its offerings include juice cleanses ranging from one to five days, ginger and turmeric shots sold in bulk packs, citrus-based juices under the Buda Zen brand, organic soups, and plant-based milks. All products are kept refrigerated from production to sale to maintain freshness. The company serves wholesale clients. It was founded in 2013 and is based in Dallas, Texas.
What is BUDA's market cap?
Buda Juice Inc. (BUDA) is a listed stock with a live quote. The latest market cap on this page is $82.9M.
Where is Buda Juice Inc. headquartered?
Buda Juice Inc. is headquartered in Dallas, TX.
How do I get BUDA news from the API?
Call GET /v1/news?tickers=BUDA. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does BUDA news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for BUDA, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the BUDA price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs